Clinical ink’s Post

View organization page for Clinical ink, graphic

8,190 followers

We are delighted to welcome our new Chief Medical Officer, Dr. Nicholas Alp, MD PhD FACC. Dr. Alp brings more than 30 years of clinical research expertise to Clinical ink, and will lead the creation of innovative solutions and commercial strategies for clinical trial technology based on his experience as an interventional cardiologist and clinical trialist. Read the announcement here: https://lnkd.in/eBFijFst

  • No alternative text description for this image
Charmi S

Business Development at Evia Search

4mo

Fantastic, and Congratulations Dr. Nicholas! We at EviaSearch, www.eviasearch.com wish you the very best for your new role and responsibilities filled with success and fulfilment. 

Like
Reply
Tim BEARPARK, MSc, MBA, DCR(T)

✪ VP ▫️ Transformational Leader ▫️ Business Growth Strategy and Scaling ▫️ Life Science Business Development Innovation

4mo

Exciting news today from Clinical ink. Welcome to the team Nick.

Like
Reply

Looking forward to meeting you.

Like
Reply
William (Bill) Marshall

Vice President, Medical, Cincor

4mo

Good for Nic. Always liked him.

Steve Westaby

Medical Director at Celixir

4mo

You don’t seem to have aged at all Nick. Wishing you the best in your new role. Steve

Like
Reply
Justin Stebbing

Editor-in-Chief of Oncogene, Professor of Biomedical Sciences, ARU, Cambridge, Visiting Professor of Oncology, Imperial College, London, Phoenix Hospital Group, VP Graviton

4mo

super news congratulations

Like
Reply
Stuart Roeves

Vice President | Clinical Ink

4mo

Exciting news, to welcome Nick to the Clinical Ink team.

Like
Reply
Stephen Brandao

Strategic relationship manager | Clinical research | Helping sponsors accelerate drug and device approvals

4mo

Nick is one of the industry's very best! Congratulations, everyone.

Like
Reply
Terence Eagleton

Vice President, Medical Affairs, Europe, the Middle East, and Africa

4mo

Go Nick! Clinical Ink is very fortunate to have you. All the best. Terence

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics